Westlake Therapeutics

company

About

The company is committed to the development of a variety of innovative cell therapy products for rare diseases, cancer, etc.

  • Hangzhou,Zhejiang,China

Details

Last Funding Type
Series Unknown
Last Funding Money Raised
¥100M
Industries
Biotechnology,Health Care,Pharmaceutical,Product Research
Founded date
Jan 1, 2019
Operating Status
Active
Legal Name
West Biomedical Technology (Hangzhou) Co., Ltd.
Also Known As
West Lake Biopharmaceuticals,West Biomedical Technology (Hangzhou) Co., Ltd.,West Biomedicine

Q1 2022 c-suite not found.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
¥100M
Westlake Therapeutics has raised a total of ¥100M in funding over 2 rounds. Their latest funding was raised on Jul 15, 2021 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jul 15, 2021 Series Unknown ¥100M 4 Sequoia Capital China Detail

Investors

Number of Lead Investors
Number of Investors
1
4
Westlake Therapeutics is funded by 4 investors. Sequoia Capital China and Stow Capital are the most recent investors.
Investor Name Lead Investor Funding Round
Sequoia Capital China Yes Series Unknown
Stow Capital Series Unknown
CD Capital Series Unknown
Fang Group Series Unknown

Employee Profiles

Number of Employee Profiles
1
Westlake Therapeutics has 1 current employee profiles, including Executive Xiaofei Gao
Executive